e-connect banner
October 20, 2016 Printable Version

Seeking Feedback on Non-Sterile Compounding Standards

The College is currently seeking feedback on the Model Standards for Pharmacy Compounding of Non-Sterile Preparations developed by the National Association of Pharmacy Regulatory Authorities (NAPRA).

These draft standards have been developed to provide those who compound non-sterile preparations with the standards necessary to evaluate practice, develop procedures, and implement quality control measures, thereby improving quality and safety for both staff and patients. Along with other provincial pharmacy regulators, OCP will compile the views of members and submit feedback to NAPRA.

NAPRA will review the submissions of pharmacy regulators across the country and determine what changes to make to these draft standards, if any. Once NAPRA finalizes the standards, OCP council will consider the timing of their implementation.

Please provide your feedback on this open consultation. The feedback deadline is November 17, 2016.


Continuous Quality Improvement: Learning From Medication Incidents and Near Misses

Continous Quality Improvement (CQI)

Continuous quality improvement, or CQI, involves a set of actions that lead to improvements in healthcare services and patient outcomes. Implementing the appropriate framework is essential in ensuring that practitioners are delivering the best possible patient care and that medication incidents and near misses are being appropriately handled.

This is a reminder that all pharmacies are required to have a defined process in place to identify and resolve systemic issues, share learnings with team members, and implement appropriate changes accordingly.

Pharmacies are also encouraged to report incidences externally to help identify national trends and support broader enhancements to the healthcare system.

Learn more in the Pharmacy Connection article "CQI Benefits Patients in Community Pharmacies"


Guidance to Minimize the Loss and Theft of Controlled Substances Within Pharmacies

Health Canada stamp

The issue of opioid dependency and overdose is an ongoing concern across Canada with fentanyl being the number one cause of opioid-related deaths in Ontario last year.

This is a reminder that Health Canada has provided guidance to pharmacists and their staff on the essential steps that should be taken to minimize the loss and theft of controlled substances within pharmacies.

Regulations within the Controlled Drugs and Substances Act (CDSA) require that pharmacists take all reasonable steps necessary to mitigate the risk of diversion of controlled substances and precursors on their premises or under their control.

Read the guidance letter from Health Canada

Share Email: forward to friend Share FB Share Twitter Share LinkedIn

e-Connect is the official method of notification to pharmacists and pharmacy technicians registered with the Ontario College of Pharmacists. Please DO NOT unsubscribe if you are an OCP member. If you unsubscribe you will NOT receive important news and updates from the College, including the quarterly publication Pharmacy Connection. You may review archived issues of e-Connect on the College website.


Ontario College of Pharmacists
483 Huron Street
Toronto, ON M5R 2R4